Published 2 days ago • loading... • Updated 21 hours ago

UK health regulator approves higher dose of Novo's Wegovy for obesity patients

On January 6, Britain's Medicines and Healthcare products Regulatory Agency approved a maximum weekly dose of 7.2 mg Wegovy, administered as three separate injections.
Evidence of greater weight loss prompted regulators and the company to revisit dosing, with Novo Nordisk chief executive Mike Doustdar saying the company initially took a cautious approach.
The MHRA approved the tripled 7.2 mg dose for patients with a BMI of 30 or higher, excluding those with BMI below 30 or using Wegovy for cardiovascular risk, requiring four weeks on the standard dose before escalation.
Shares of Novo Nordisk rose more than 5% on Friday after early prescription data showed around 3,100 filled in the first week of the U.S. launch of the Wegovy pill, boosting hopes to regain share from Eli Lilly this year.
With an MHRA ruling pending on the pill already approved in the United States, both oral drugs could provide options for up to 85 million people while injectables address around 15 million.

Insights by Ground AI

18 Articles

European Stocks Post Fifth Weekly Advance; Novo Nordisk Rises

(Bloomberg) — European stocks posted their fifth straight weekly advance as investors remained confident about artificial intelligence demand. Novo Nordisk A/S jumped 6.5% after the UK regulator approved a higher dose of its obesity drug.

1 day ago·Canada

Read Full Article

CNBC

+2 Reposted by 2 other sources

Center

Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch

The early data is a boost to the Danish drugmaker's hopes of winning back more market share from Eli Lilly this year in the obesity drug space.

1 day ago·United States

Read Full Article

Pharmaphorum

Center

Wegovy pill shows strong early uptake, as rival looms

Encouraging early sales data for oral Wegovy has buoyed Novo Nordisk, as Lilly waits for an FDA decision on its rival orforglipron, now due in Q2

1 day ago

Read Full Article

Politiken

Lean Left

Signs of Good Launch of Wegovy Pill in the Us Send Novo Shares Up

Novo shares rise by over six percent on Friday. Analyst points to prescription numbers from the US after pill launch.

2 days ago·Copenhagen, Denmark

Read Full Article

breakingthenews.net

Reposted by

BizToc

Center

Novo Nordisk up 6% as UK approves higher dose of Wegovy

Shares of Danish pharmaceutical company Novo Nordisk A/S surged more than 6% on Friday after the United Kingdom's regulator approved a higher dose of weight-loss drug Wegovy for patients with obesity....

2 days ago

Read Full Article